The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack.

11 нояб. 2023 г. · The ARTEMIS study will be conducted globally and is scheduled to begin patient enrollment in mid-2024.

The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack.

We are doing this study to see if a new medicine, ziltivekimab, can be used to treat people who have been admitted to hospital because of a heart attack.

2 апр. 2024 г. · Join the ARTEMIS research study to investigate the effectiveness of ziltivekimab in treating heart attack patients.

13 нояб. 2023 г. · A new global cardiovascular study called ARTEMIS, which will investigate the effectiveness of an IL-6 inhibitor for treatment of acute myocardial infarction.

31 окт. 2023 г. · ARTEMIS - A Research Study to Look at How Ziltivekimab ... According to the Novo Nordisk disclosure commitment on novonordisk-trials.com.

8 февр. 2024 г. · Full data ; ARTEMIS - Effects of Ziltivekimab Versus Placebo on Cardiovascular Outcomes in Patients With Acute Myocardial Infarction · Ongoing.

Novo Nordisk clinical trials are conducted at more than 5,000 trial sites. There are more than 50 countries around the world that host Novo Nordisk clinical ... Find Study Results · Contact Us · Sharing clinical study data · Cookie list

Delicious. November 15, 2024. ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack (clinicaltrials ...